Featured Research

from universities, journals, and other organizations

Fetal 'programming' of sweet taste's elicited pleasure

Date:
July 30, 2013
Source:
Society for the Study of Ingestive Behavior
Summary:
New research finds that adversities during gestation may influence the newborn's pleasure in response to sweet.

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that feeding behavior and preferences may be shaped very early during development, even during fetal life.

Newborns of different species react to the sweet taste demonstrating facial expressions of pleasure, such as licking (tongue protusions) and thumb sucking. These "hedonic" responses are related to brain activity in regions that respond to pleasure and reward.

In this study, rat pups derived from dams that experienced undernutrition during gestation (intra-uterine growth restricted, IUGR) and controls received a droplet of sucrose solution or water at their first day of life. When compared to controls, IUGR newborns demonstrate an increased and more prolonged hedonic response to sucrose versus water.

We and others have previously described that, in humans, these IUGR individuals demonstrate altered feeding preferences at different adult ages, eating more sugars and fatty foods, and less fruits and vegetables. We also have shown that fetal growth correlates with the hedonic responses to sweet taste in preterm newborns born at 27 weeks gestation.

This becomes of importance when it is well established that poor fetal growth is associated with an increased risk for chronic diseases in adulthood (cardiovascular disease, type II diabetes, atherosclerosis). Therefore, a persistent alteration in food preferences in individuals exposed to fetal adversity possibly contributes to the development of these diseases. Our animal model will allow a deeper understanding of the mechanisms involved in these processes.

"This translational approach permits us to study different systems that may affect food preferences in IUGR individuals, which will point out to targets for intervention planning," said lead researcher Roberta Dalle Molle. As more than 20 million children are born low birth weight annually worldwide, part of whom will become adults with the chronic diseases described above, the understanding of how early life may shape the individuals' eating behavior and preferences is of great importance.


Story Source:

The above story is based on materials provided by Society for the Study of Ingestive Behavior. Note: Materials may be edited for content and length.


Cite This Page:

Society for the Study of Ingestive Behavior. "Fetal 'programming' of sweet taste's elicited pleasure." ScienceDaily. ScienceDaily, 30 July 2013. <www.sciencedaily.com/releases/2013/07/130730091405.htm>.
Society for the Study of Ingestive Behavior. (2013, July 30). Fetal 'programming' of sweet taste's elicited pleasure. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/07/130730091405.htm
Society for the Study of Ingestive Behavior. "Fetal 'programming' of sweet taste's elicited pleasure." ScienceDaily. www.sciencedaily.com/releases/2013/07/130730091405.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins